Show simple item record

dc.contributor.authorBenbaba, S
dc.contributor.authorIsaakidis, P
dc.contributor.authorDas, M
dc.contributor.authorJadhav, S
dc.contributor.authorReid, T
dc.contributor.authorFurin, J
dc.date.accessioned2015-12-30T21:30:06Zen
dc.date.available2015-12-30T21:30:06Zen
dc.date.issued2015-12-29en
dc.identifier.citationDirect Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?, 10 (12):e0144936 PLoS ONEen
dc.identifier.issn1932-6203en
dc.identifier.pmid26713873en
dc.identifier.doi10.1371/journal.pone.0144936en
dc.identifier.urihttp://hdl.handle.net/10144/592662en
dc.description.abstractDirectly-observed therapy (DOT) is recommended for drug-resistant tuberculosis (DR-TB) patients during their entire treatment duration. However, there is limited published evidence on implementation of direct observation (DO) in the field. This study aims to detail whether DO was followed with DR-TB patients in a Médecins Sans Frontières (MSF) tuberculosis program in Mumbai, India.
dc.languageENGen
dc.language.isoenen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen
dc.titleDirect Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?en
dc.identifier.journalPloS Oneen
refterms.dateFOA2019-03-04T12:39:21Z
html.description.abstractDirectly-observed therapy (DOT) is recommended for drug-resistant tuberculosis (DR-TB) patients during their entire treatment duration. However, there is limited published evidence on implementation of direct observation (DO) in the field. This study aims to detail whether DO was followed with DR-TB patients in a Médecins Sans Frontières (MSF) tuberculosis program in Mumbai, India.


Files in this item

Thumbnail
Name:
151229 Do we really DO.pdf
Size:
286.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record